Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Mallinckrodt
Julphar
Chubb
McKesson
Cantor Fitzgerald
Boehringer Ingelheim
Merck

Generated: May 27, 2018

DrugPatentWatch Database Preview

TAZORAC Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Tazorac patents expire, and when can generic versions of Tazorac launch?

Tazorac is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in TAZORAC is tazarotene. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the tazarotene profile page.
Drug patent expirations by year for TAZORAC
Pharmacology for TAZORAC
Ingredient-typeRetinoids
Drug ClassRetinoid
Synonyms for TAZORAC
118292-40-3
15146-EP2275420A1
15146-EP2295055A2
15146-EP2295416A2
15146-EP2298748A2
15146-EP2298764A1
15146-EP2298765A1
15146-EP2298768A1
15146-EP2305642A2
15146-EP2308861A1
15146-EP2311453A1
15146-EP2311808A1
15146-EP2311829A1
15146-EP2314590A1
15146-EP2316832A1
15146-EP2316833A1
292T403
3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester
3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-,ethyl ester
4CA-1215
6-(4,4-Dimethyl-thiochroman-6-ylethynyl)-nicotinic acid ethyl ester
6-(4,4-dimethylthiochroman-6-ylethynyl) nicotinic acid ethyl ester
6-[(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid ethyl ester
6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-pyridinecarboxylic Acid Ethyl Ester
6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid ethyl ester
6-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylicacidethylester
81BDR9Y8PS
AB0012671
AB01274801_02
AB01274801-01
AB2000146
ABP000994
AC-755
AC1L1K88
Acnitaz
ACT06773
AGN 190168
AGN-190168
AJ-26850
AK-73028
AKOS015902872
AN-15540
ANW-45265
Avage
Avage (TN)
AX8041205
BC201578
BCP0726000163
BDBM50265951
BIDD:GT0293
BR-73028
BS-1012
C-23771
C12531
C21H21NO2S
CAS-118292-40-3
CC-34651
CHEBI:32184
CHEMBL1657
CJ-24315
CS-1029
CTK8B4490
D01132
D0BM5G
DB00799
DR001785
DSSTox_CID_26691
DSSTox_GSID_46691
DSSTox_RID_81825
DTXSID5046691
EBD38650
Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate
Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate;6-(4,4-dimethyl-thiochroman-6-ylethynyl)-nicotinic acid ethyl ester
ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)-ethynyl)nicotinate
ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate
ethyl 6-[(4,4-dimethyl-3,4-dihydro-2H-thiochromen-6-yl)ethynyl]nicotinate
Ethyl 6-[(4,4-dimethyl-3,4-dihydro-2H-thiochromen-6-yl)ethynyl]pyridine-3-carboxylate
ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate
ethyl 6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxylate
Ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)-ethynyl]nicotinate
ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl] nicotinate
Ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinate
ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate
Fabior
Fabior (TN)
FT-0652578
GTPL6952
HE299896
HMS3655K05
HY-15388
I14-1992
KB-80817
LS-130838
MFCD00867628
MLS003915630
MolPort-005-932-693
NCGC00167525-01
NCGC00167525-02
NCGC00167525-03
OGQICQVSFDPSEI-UHFFFAOYSA-N
PubChem24431
Q-102516
RTR-034197
S-7551
s1569
SC-19506
SCHEMBL3134
SMR002096194
SR-01000931253
SR-01000931253-2
ST2419369
Suretin
tazarotene
Tazarotene (Avage)
Tazarotene (JAN/USAN/INN)
Tazarotene [USAN:INN:BAN]
Tazarotene [USAN:INN]
tazaroteno
tazarotenum
Tazorac (TN)
Tazorac, Avage, Zora, Tazarotene
Tazorac;Avage;Zora;Avage
Tazoral
Tox21 112522
Tox21_112522
Tox21_112522_1
TR-034197
UNII-81BDR9Y8PS
ZINC1542199
Zora
Zorac
Zorac (TN)
Zorac|||Tazorac

US Patents and Regulatory Information for TAZORAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-001 Sep 29, 2000 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-002 Jun 13, 1997 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-002 Sep 29, 2000 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-001 Jun 13, 1997 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for TAZORAC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-002 Jun 13, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-001 Jun 13, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene CREAM;TOPICAL 021184-001 Sep 29, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan TAZORAC tazarotene GEL;TOPICAL 020600-002 Jun 13, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Army
US Department of Justice
Fish and Richardson
Covington
Colorcon
Moodys
Deloitte
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.